跳至主要内容
临床试验/NCT00263159
NCT00263159已完成不适用

Pharmaceutical Care for Asthma Control Improvement

University Ghent2 个研究点 分布在 1 个国家目标入组 221 人开始时间: 2006年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
221
试验地点
2
主要终点
The difference between study groups in the change of asthma control from baseline and follow-up visits

研究概览

简要总结

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.

详细描述

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients. Patients will be randomly allocated to the control group (= no input from pharmacist) or intervention group (= with pharmaceutical care at baseline and follow-up visits over 6 months).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with persistent asthma
  • Asthma treatment for at least 12 months
  • Regular visitors of the participating community pharmacy

排除标准

  • Severe co-morbidity
  • > 10 pack-years smoking history
  • Asthma Control Test score < 15 or =25

结局指标

主要结局

The difference between study groups in the change of asthma control from baseline and follow-up visits

时间窗: after 1, 3 and 6 months

次要结局

  • Peak flow(after 3 and 6 months)
  • Knowledge of asthma and treatment(after 6 months)
  • Asthma quality of life questionnaire (AQLQ)(after 6 months)
  • Therapy adherence
  • Inhalation techniques(after 6 months)
  • Smoking(after 6 months)
  • Asthma exacerbations(after 6 months)
  • General Practitioner (GP) visits, emergency room visits and hospitalisations
  • Working days lost and school days lost

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验